ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
RespireRx Pharmaceuticals Inc (PK)

RespireRx Pharmaceuticals Inc (PK) (RSPI)

0.0029
-0.0001
(-3.33%)
Closed June 19 4:00PM

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
0.0029
Bid
0.0027
Ask
0.003
Volume
17,326,258
0.0025 Day's Range 0.0033
0.0006 52 Week Range 0.0069
Market Cap
Previous Close
0.003
Open
0.0031
Last Trade Time
Financial Volume
$ 47,959
VWAP
0.002768
Average Volume (3m)
23,491,755
Shares Outstanding
365,418,647
Dividend Yield
-
PE Ratio
0.00
Earnings Per Share (EPS)
-0.01
Revenue
-
Net Profit
-3.97M

About RespireRx Pharmaceuticals Inc (PK)

RespireRX Pharmaceuticals Inc. is a biopharmaceutical company focused on the discovery and development of novel drug therapies for the treatment of sleep apnea, ADHD, spinal cord injury and other neurological conditions. RespireRX Pharmaceuticals Inc. is a biopharmaceutical company focused on the discovery and development of novel drug therapies for the treatment of sleep apnea, ADHD, spinal cord injury and other neurological conditions.

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Headquarters
Wilmington, Delaware, USA
Founded
1970
RespireRx Pharmaceuticals Inc (PK) is listed in the Pharmaceutical Preparations sector of the OTCMarkets with ticker RSPI. The last closing price for RespireRx Pharmaceuticals (PK) was $0. Over the last year, RespireRx Pharmaceuticals (PK) shares have traded in a share price range of $ 0.0006 to $ 0.0069.

RespireRx Pharmaceuticals (PK) currently has 365,418,647 shares outstanding. RespireRx Pharmaceuticals (PK) has a price to earnings ratio (PE ratio) of 0.00.

RSPI Latest News

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
CMTLComtech Telecommunications Corporation
$ 4.07
(87.56%)
91.43M
NLSPNLS Pharmaceutics Ltd
$ 0.2735
(84.42%)
305.35M
ASNSActelis Networks Inc
$ 2.11
(83.48%)
51.37M
RELIReliance Global Group Inc
$ 0.40
(80.18%)
394.85M
LRHCLa Rosa Holdings Corporation
$ 1.78
(71.15%)
52.9M
STISolidion Technology Inc
$ 0.6881
(-64.35%)
16.36M
DMTKDermTech Inc
$ 0.1488
(-55.25%)
10.74M
QMCOQuantum Corporation
$ 0.3752
(-51.90%)
3.14M
ZNTLZentalis Pharmaceuticals Inc
$ 4.135
(-50.72%)
21.58M
AWINAERWINS Technologies Inc
$ 1.74
(-47.90%)
1.05M
RELIReliance Global Group Inc
$ 0.40
(80.18%)
394.85M
NLSPNLS Pharmaceutics Ltd
$ 0.2735
(84.42%)
305.35M
NVDANVIDIA Corporation
$ 135.58
(3.51%)
294.32M
MBIOMustang Bio Inc
$ 0.8517
(13.56%)
291.95M
CRKNCrown Electrokinetics Corporation
$ 0.0548
(-17.10%)
92.39M

RSPI Discussion

View Posts
dinogreeves dinogreeves 5 hours ago
There are non believers and believers and between (on the fence with spice of flippers when momentum is in their favor for bread and butter), my perspective on this company and the ticker itself, either the company will prove itself or it won't, 100...200...300 thousand dollars from doctors pitching in is definitely not going to cut it, as the company has stated in their filings they need partnership, JV or buyout, the latter is definitely not likely to happen, they need to get into phase 2 and 3 get some attention. I have invested enough if it fails, so be it, 4000 grand is my investment at 10 cents that is 200,000 at 20 cents 9-12 months definitely doable with JV or partnership and advanced pipelines, that's 400,000, enough in there that I am not going sweat bullets over it, if it works out great, if it doesn't, I make that easily on a single trade.
👍️0
LTListener LTListener 6 hours ago
I’ve thought that as well.

Get all the ducks in a row and then begin unveiling company making endeavors.

A typical flash in the pan otc would have played cards differently. Curious not a peep for 3 weeks post DOD news. This says a lot! Tells me there are many more white hot irons in the fire!!
💯 1 🤑 1
LTListener LTListener 6 hours ago
Phase 2 clinical trials funded by the Department of Defense for SCI with RSPi’s asset is very significant.

Couple that with the rest of their pipeline especially advancing to final tier 3 preclinicals with the NIH for the epilepsy/pain candidate holds significant value.

Strong relationships with government agencies funding the advancement of multiple drugs. Strong pharma backgrounds of those associated with company. This bodes well for the company and more importantly patients who need better medicine. And that would be music to our ears. Maybe even from an orchestra..
👍️ 1 🥳 1
linkvest linkvest 7 hours ago
that clown is an askwipe... had it on ignore for years.. Arguing with people over stupid nonsense stuff on a stock board is how he gets his jollies off... If everyone has these clowns on ignore then they just go find another board to puke their BS on.... just stop responding. Or just laugh at them lol...
💯 1 🤣 1
NeutrinoKid NeutrinoKid 8 hours ago
I would rather say that comparing to most iHub boards this one has a number of very unusually good contributors who include links to peer-reviewed studies, and actually go through, and quote the company’s documentation, which is dense, and admittedly extremely poorly presented.

Who cares about the few jokers who come and go. They do that all over iHub, and yes sometime it’s pretty embarrassing.
👍️ 1 💯 1
THall THall 8 hours ago
Because I don't like traders getting conned out of their money with lies. This board is filled with pumpers who are trying nothing more than to dump shares on others. If that doesn't piss you off then I guess you aren't a good person.
🖕 1 🤡 1
NeutrinoKid NeutrinoKid 9 hours ago
So why do you care so much? Did they take a dump on your doorstep?
😝 1
NeutrinoKid NeutrinoKid 9 hours ago
Second essential piece of wisdom I may offer is that the forces that have kept it afloat may have perpetuated its stagnation: it’s clear that the management has been neglectful and complacent. Just to begin: ::1. The website and branding are unbelievably shitty. ::2. Their SEC paperwork is grossly delinquent.

But the good news is that, unlike the science those things are not (or should not be) challenging and complicated.
👍️ 1
THall THall 9 hours ago
Explain what exactly? It's a group of doctors and only a portion $250k could potentially go to RSPI. Again this is nothing more than a pump and dump being orchestrated. If you think $250k is going to have any impact on trading then I feel bad for you.
💩 1 🖕 1 🤡 1 🫨 1
waterpro42 waterpro42 9 hours ago
Great response on your efforts Neutrino!
👍️0
NeutrinoKid NeutrinoKid 9 hours ago
Quick note about making sense of RespireRx RSPI:

It’s challenging and complicated. The first essential piece of wisdom I may offer is that it is an anomaly. In terms of the financials, it should not exist. It has been artificially kept afloat for a long time. So why? It turns out that that part does make sense: ::1. the science is absolutely compelling, and it’s really worth it to put some effort to understand it. I posted some about that already, and I’ll write more soon. ::2. it has many patents which are comprehensive and good for years - for ex. (and it’s just one thing!) the AMPAkines, to 2037. From Wikipedia:

A wide range of ampakines have been developed by RespireRx, which hold patents covering most medical uses of this class of drugs.

https://en.wikipedia.org/wiki/Ampakine?wprov=sfti1#
👍️ 3
NeutrinoKid NeutrinoKid 9 hours ago
Explain this then: Last week, after the announcement about the DoD funding I wrote to the scientist at Shirley Ryan AbilityLab hospital who will run the 1.8 million dollar budget clinical trial of candidate compound CX-1739, from RespireRx, Dr Milap Sandhu. He replied the next day. Quoted verbatim:

Dear Bruno,

Thank you for reaching out.

Yes, we are planning to initiate a study with CX1739 in individuals with SCI. We are at early stages of this research and it'll take a few months before we begin enrollment.

Are you or someone you know has a spinal cord injury?

Best regards,
Milap
👍️ 3
Dyno89 Dyno89 9 hours ago
Rocks for brains would be an improvement for you. He was actually giving you a compliment.
👍️ 1 💯 1
THall THall 9 hours ago
Cant handle the truth huh? Most bag holders deny the truth when they fall for pump and dump scams like RSPI

Yeah Im the one with rocks for brains LMAO. They are 2 months late filing the 10k even after getting an extension. This POS can be suspended from trading at any minute.


Pink Limited Information
Company is not current in its reporting obligations under Section 13 or 15(d) of the Exchange Act.
Delinquent SEC Reporting IconDelinquent SEC Reporting
Transfer Agent Verified IconTransfer Agent Verified


RespireRx Pharmaceuticals Inc. (the “Registrant”) was unable, without unreasonable effort or expense, to file its Annual Report on Form 10-K for the period ended December 31, 2023 (the “Annual Report”) by the April 1, 2024 filing date applicable to smaller reporting companies due to a delay experienced by the Registrant in completing its financial statements due to additional time needed for the Board of Directors (acting as the Audit Committee) of the Registrant to complete its review of the Annual Report with the Registrant’s independent registered accounting firm. As a result, the Registrant is still in the process of preparing disclosures and accumulating validating information needed to complete the Annual Report. The Registrant intends to file a complete Annual Report as soon as practicable within the extension period of fifteen calendar days provided under Rule 12b-25 of the Securities Exchange Act of 1934, as amended.
🖕 1 🫨 1
crazy horse 0 crazy horse 0 10 hours ago
Thank you Intelligent Posters are in Demand LOL

Member marked you

No. I am just a DD hound but have been invested in other pharmas in the past on the OTC. They can be explosive. There is also plenty of risk in pharma too.

I like the risk v. reward ratio here for my speculative monies.
👍️0
ajd ajd 11 hours ago
Thanks I have spent hrs reading I love doing DD..
👍️0
LTListener LTListener 11 hours ago
I think one of the greatest things about investing is every individual has the opportunity to complete their own due diligence and interpret it all with their own discretion. My interpretation may be way off another’s.

PR’s, company website, SEC filings have a bunch of information to review. Good luck to all.
👍️ 2
ajd ajd 12 hours ago
Would love to see LTL compose a DD package and we could have it posted in the I-BOX !! What do you think LTL you up 4 it !!
👍️ 2
LTListener LTListener 12 hours ago
No. I am just a DD hound but have been invested in other pharmas in the past on the OTC. They can be explosive. There is also plenty of risk in pharma too.

I like the risk v. reward ratio here for my speculative monies.
👍️0
crazy horse 0 crazy horse 0 12 hours ago
Question did you at one time work in the Pharmaceuticals you seem knowledgeable in this area

Thanks, but it is not that difficult. I just read the last dozen or so PR, SEC filings and watch the CEO interviews, review their website presentations, etc.

I would highly recommend prospective investors spend a full day reviewing all this information and then start to use logic and put 2 and 2 together. Pharma like any OTC is risky. But one can see how the company has approached preclinicals to mitigate some risk in development.

And then the share structure is fine and while some warrants and conversions will add to the outstanding shares eventually, it is not outlandish. Even if the shares double here, the market valuation is still peanuts.

People tell stories of how this or that pharma went ballistic. Some of those stocks went 200-1000 times at their peak. And none of them hold a candle to the potential baked within RSPI pipeline and the medical indications they are trying to address. This is currently trading roughly 3x the floor the past year. I think this is why you are seeing longs so excited the ball has started rolling and others more desperate to position.
👍️ 1 💯 1
hotrodemon hotrodemon 12 hours ago
You are so delusional, I am not going to debate someone with the I.Q of gravel.
👍️ 3 💯 1
THall THall 13 hours ago
Another red day for the diluted pile of shit pump and dump. Fly that yield sign proud you worthless scam..

No way in hell the government is giving this scam money when they cant even file SEC papers. Next step Caveat Emptor and revocation.
💩 1 🖕 1 🤡 2 🫨 1
waterpro42 waterpro42 14 hours ago
Markets closed tomorrow, folks need their beer money.
🙄 1 🫨 1
BIOCHEMUP BIOCHEMUP 14 hours ago
0.0025 x 0.0026
🖕 1 🤡 1
hondobud hondobud 14 hours ago
I guess all the flipper money will clear on Thursday now.....Go RSPI!
👍️0
LTListener LTListener 15 hours ago
Thanks, but it is not that difficult. I just read the last dozen or so PR, SEC filings and watch the CEO interviews, review their website presentations, etc.

I would highly recommend prospective investors spend a full day reviewing all this information and then start to use logic and put 2 and 2 together. Pharma like any OTC is risky. But one can see how the company has approached preclinicals to mitigate some risk in development.

And then the share structure is fine and while some warrants and conversions will add to the outstanding shares eventually, it is not outlandish. Even if the shares double here, the market valuation is still peanuts.

People tell stories of how this or that pharma went ballistic. Some of those stocks went 200-1000 times at their peak. And none of them hold a candle to the potential baked within RSPI pipeline and the medical indications they are trying to address. This is currently trading roughly 3x the floor the past year. I think this is why you are seeing longs so excited the ball has started rolling and others more desperate to position.
💯 1 🤑 1
crazy horse 0 crazy horse 0 15 hours ago
Your Very thorough on your research Thanks

Absolutely. The DOD contract itself came out of the blue to those of us who have owned shares more than 24 hours at a time..

The CEO essentially said the epilepsy/pain candidate is in tier 3 NIH preclinicals, which if successful would open the door to grant money. This could be wrapping up at any moment.

In addition to that, they are seeking purse strings to open and help support, so BP could enter into a deal likewise at any moment. IMO, likely to be multiple deals.

.. From my DD, I think the epilepsy preclinical work is a slam dunk and BP/funding for human trials could be any moment. The pain models and addicitive liability testing will probably help determine the paths with or without BP to address opioid crisis, which is high profile and the entire reason the NIH was interested in KRM-ll-81.

And they have a candidate that has shown positive results for ADHD. Also the OSA program in Australia has some funding in place and they could launch into human clinicals at any moment. The pipeline here is loaded with potential for sure.

I think this will gradually work its way higher with bursts on news or buying pressure and consolidation of the sheep. All the while big fish and whales will be absorbing the float. Trickle up to 1,2,3,5 pennies, etc and then a large BP deal surfaces and we see .10-.20 or much muc more depending on the extent of the deal(s).

Their filings basically stated all their drug programs should be partnered, JV, sold, etc. The filings also show that insiders and institutional are taking up equity ownership positions... All of this does not indicate a simple .003,.004, .005 stock with market cap under 5 million. The value in the IP alone is in the 10s of millions and further exposure to the whales and inking some additional development deals will see valuations in the 100s of millions. Not today; not tomorrow, but in my opinion over the summer and before the bearded man flies, we will be trading well into silver land...

But good luck to everyone in their strategy. The market accepts all kinds of approaches and wealth generally flows from the impatient to the patient...
👍️ 4
LTListener LTListener 15 hours ago
I dont think it will for the equity itself, but certainly I would think individual candidate drugs from their pipeline could be sold or bought out. The company itself said it believes all their pipeline should be sold, partnered, JV, etc, etc.

I am sure the insiders and institutional supporting this have an idea what their pipeline is worth or could be worth with some additional preclinical or early phase trials and BP activity. It is only logical with the insiders and instituional acquiring equity ownership positions in RSPI, that they will do everything to unlock the value of their IP and maximize ROI on their pipeline/investment.
👍️ 2 💯 2 🤑 1
hondobud hondobud 15 hours ago
Signals? GLTA HB
👍️0
elks elks 16 hours ago
Cream always flows to the top tic toc. Rspi.
👍️0
The Night Stalker The Night Stalker 16 hours ago
https://stockcharts.com/h-sc/ui?s=rspi&p=W&yr=1&mn=6&dy=0&id=p24986097784&listNum=23&a=1113701411
👍️0
LTListener LTListener 16 hours ago
Absolutely. The DOD contract itself came out of the blue to those of us who have owned shares more than 24 hours at a time..

The CEO essentially said the epilepsy/pain candidate is in tier 3 NIH preclinicals, which if successful would open the door to grant money. This could be wrapping up at any moment. In addition to that, they are seeking purse strings to open and help support, so BP could enter into a deal likewise at any moment. IMO, likely to be multiple deals... From my DD, I think the epilepsy preclinical work is a slam dunk and BP/funding for human trials could be any moment. The pain models and addicitive liability testing will probably help determine the paths with or without BP to address opioid crisis, which is high profile and the entire reason the NIH was interested in KRM-ll-81.

And they have a candidate that has shown positive results for ADHD. Also the OSA program in Australia has some funding in place and they could launch into human clinicals at any moment. The pipeline here is loaded with potential for sure.

I think this will gradually work its way higher with bursts on news or buying pressure and consolidation of the sheep. All the while big fish and whales will be absorbing the float. Trickle up to 1,2,3,5 pennies, etc and then a large BP deal surfaces and we see .10-.20 or much muc more depending on the extent of the deal(s).

Their filings basically stated all their drug programs should be partnered, JV, sold, etc. The filings also show that insiders and institutional are taking up equity ownership positions... All of this does not indicate a simple .003,.004, .005 stock with market cap under 5 million. The value in the IP alone is in the 10s of millions and further exposure to the whales and inking some additional development deals will see valuations in the 100s of millions. Not today; not tomorrow, but in my opinion over the summer and before the bearded man flies, we will be trading well into silver land...

But good luck to everyone in their strategy. The market accepts all kinds of approaches and wealth generally flows from the impatient to the patient...
👍️ 2
crazy horse 0 crazy horse 0 16 hours ago
You are a real Menace

Take a deep breath dawg. Any rise from here is a pointless, which will be caught with a dump after.

The reason we all holding is future news in q3 or q4 for the results of their research and if they get bought out. Until we hear word on that price action here is literally pointless unless u trying to fill for 20-40 percent.

Once fillings hit we will reach new highs then back to days like these. But if word gets back that their trails are a success will be far into cents and laugh about these days.

But that won’t come till fall. Decide what u want to do flip for date money or take a chance on gaining house money.
👍️ 2 💯 1
Menace212 Menace212 16 hours ago
Yeah got 3m in this 0022 average.
🫨 1
dinogreeves dinogreeves 16 hours ago
You need to keep your eyes on the ball, daily gyrations don't matter, the end goal is what matters, things can change in a blink here. Unless you are trying to make bread and butter. If you are holding few million shares it will go a long way once this gets current and news starts to flow in.
👍️ 1 💩 1 🤡 1 🤥 1 🧌 1 🪦 1
Menace212 Menace212 16 hours ago
Definitely holding out for 5c. I hope ur right. Just understanding the timing of these things are definitely tricky.

We will see tho.

Never the less I’m just keeping a pessimistic view point on time to mentally instill patience on this!
🖕 1 🫨 1
BIOCHEMUP BIOCHEMUP 16 hours ago
$0.003.
👍️ 1
fly_fisherman fly_fisherman 16 hours ago
I disagree completely....

But that probably won’t come till after summer, we will definitely get a pump for fillings. But it will dip again until we heard word if they being bought out. That’s what everyone is holding for.

Any speculation of timing like that is nonsense. Yesterday you were touting .05 cent bull run anytime. You are in a state of confusion and making the best of it. A typical OTC may drop back down, but not a pharma with a DoD contract in hand with one of their lower end drugs I might add. A pipeline loaded with High Exposure in need drugs.

Nope, if this stock pulls back, it could be after hitting.05 and settling in the .025 range for a new base.

Words of advice. Do not underestimate where this can go. Dollars available in BP's war chest has quadrupled over the last 3 years. Just a matter of time!!!

Patience!!!
👍️ 3 👜 1 💩 1 💯 2 😍 1 🤑 1
Menace212 Menace212 16 hours ago
Why u care how another person speaks. Just saying my opinion off of what I seen in otc stocks similar to this one.
Hating is a disgusting feature DAWG!
👍️ 1 🖕 1 🫨 1
boywonder1 boywonder1 16 hours ago
Dawg is so outdated like you. You do not control price action, fool!!!!!💪 You no nothing about bio stocks either! Get lost, as you are a price manipulator. You sold!!!! POS. Your manner speech is disgusting DAWG. Learn how to speak !!!! Thanks hater
😂 1
Menace212 Menace212 16 hours ago
Dawg I’m saying rn levels from here is pointless to look at or watch till we hear news about their results. Like obsessing about daily price action is literally meaningless, bc if we get what we are waiting for we will fly to cents. But that probably won’t come till after summer, we will definitely get a pump for fillings. But it will dip again until we heard word if they being bought out. That’s what everyone is holding for.
👍️ 1 🖕 1 🤡 1
Dj56 Dj56 17 hours ago
Is it not in the interest of ONE BP simply buying rspi out, and rspi to be bought, with achievement levels reached being big pay dates so buying on accomplishment time, not all payment at once, so as too keep all in house for the ONE BP rather than lose any or all to ANOTHER BP, while RSPI.solidifies a financial backing for all future R and D?
👍️0
powerbattles powerbattles 17 hours ago
The company has filled the third quarter of 2023. Right now, we're awaiting the fourth quarter, which is the 10k report, and the first quarter of 2024.
"Any rise from here is pointless. Are you telling us any rise from here is meaningless? To be frank, that's just your perspective. It won't affect the share price. Just because you say that doesn't mean the stock won't go up and maintain those gains. No one can predict the market. Anything can happen in the OTC market. One piece of good news could easily push it up another +600 or more. Those who sold at .0008 and more recently at .0017 to .002 once held your exact mindset, the same viewpoint demonstrating a significant lapse in judgment.

Some investors who bought at prices much higher, like .004 to .006, are still holding because they expect the stock to surpass those levels significantly.

"Any rise from here is pointless. That's simply absurd. With the Department of Defense funding and at its current price, the stock is severely undervalued in my opinion.
👍️ 2 👜 1 💩 1 💯 1 🤑 1
TrendTrade2016 TrendTrade2016 17 hours ago
DROPPING HARD NOW...BACK TO .002
🎯 1 👍️ 1 🖕 1 🤡 1
jor8888 jor8888 17 hours ago
yep buyout will be at $1-$10 range whocares about anything less than a penny movement
👍️0
halbroke1 halbroke1 17 hours ago
RSPI $$$ ANY POSSIBILITY OF A HUGE BUYOUT HERE, I THINK THIS GEM IS A PRIME TARGET!!!, IT COULD COME AT ANYTIME..THE HUGE PHARMAS ARE PROBABLY EYEING THIS ONE ..OPINIONS, ANYONE..
👍️ 1
fly_fisherman fly_fisherman 17 hours ago
Basing at a Much Higher Level...

Pretty simple. The stronger the higher base as news, filings, etc. hits the higher we go!! This takes time and is healthy.

This is a far cry from starting in the trips. ALL GOOD!

Bottom Line: Dirt cheap. Undervalued comparatively even at these levels. DoD was a game changer. When its time it won't take months to reach proper valuation. It could happen in days! So, folks thinking they can sell and buy back in. Be careful. The pharma's can leave you in the dust. Especially now with the word getting out and the higher base!

Patience!
👍️ 2 💯 1 🤑 1
Dj56 Dj56 17 hours ago
Gotcha, thanks
👍️ 1
Menace212 Menace212 17 hours ago
Take a deep breath dawg. Any rise from here is a pointless, which will be caught with a dump after.

The reason we all holding is future news in q3 or q4 for the results of their research and if they get bought out. Until we hear word on that price action here is literally pointless unless u trying to fill for 20-40 percent.

Once fillings hit we will reach new highs then back to days like these. But if word gets back that their trails are a success will be far into cents and laugh about these days.

But that won’t come till fall. Decide what u want to do flip for date money or take a chance on gaining house money.
👍️ 1 🖕 1 🫨 1
Dj56 Dj56 17 hours ago
Np....always had a slow learning curve, and a big picture frame of mind.

As if that weren't bad enough...
Now in my 67th year of befuddlement, 4 and 5 year olds routinely arrive at the correct conclusion before I do, when I engage with them in watching an episode of 'Blue's Clues'.
👍️0